The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Immunicum AB: Year-end Report FY 2016 (2017-02-17)
Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immuno-oncology treatment against a range of solid tumors, today announced financial results for the year ended December 31, 2016 and provided a corporate update and ove...
- Medivir A: Financial Statement, January – December 2016 (2017-02-17)
Significant events during the fourth quarter Medivir focuses research and development operations exclusively on oncology and reorganises in order to achieve significant cost savings. As a result of the operative transformation a non-recurring sum of SEK 49.1 m...
- Cerenis Therapeutics Reports 2016 Annual Results (2017-02-17)
Cerenis Therapeutics (FR0012616852- CEREN), an international biopharmaceutical company dedicated to the discovery and development of innovative HDL therapies (“good cholesterol”) for treating cardiovascular and metabolic diseases, today announces its full-year 2016...
- Sartorius Enters Corporate Partnership Program with EMBL (2017-02-17)
> Sartorius and EMBL join forces to offer advanced training and science education > Sartorius is now a member of the group of corporate EMBL partners aiming to connect industry to academia Sartorius, a leading international laboratory and pharmaceutical equipm...
- Lonza Houston to Produce AAV-based Gene Therapy for Selecta (2017-02-16)
Lonza Houston, Inc., a global leader in viral gene and cell therapy manufacturing, and Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biopharmaceutical company focused on developing biologic therapies for rare and serious diseases that avoid unwanted im...
- BioMedPartners Raises CHF75m in First Closing of New VC Fund (2017-02-16)
BioMedPartners today announced the first closing of BioMedInvest III, their third equity venture capital fund, at CHF 75 million. BioMedInvest III is a healthcare venture capital fund which invests in private early-to-midstage companies in Switzerland, Germany a...
- Almac Diagnostics Appoints Leeona Galligan VP UK Operations (2017-02-16)
Almac Diagnostics, the global personalised medicine company, focusing on the discovery, development and commercialisation of complex diagnostic and companion diagnostic tests, has announced the appointment of Dr. Leeona Galligan (PhD, FRCPath) to the position of Vi...
- Update on CRISPR/Cas9 U.S. Patent Interference Proceedings (2017-02-15)
> UC’s patent application covering the use of CRISPR/Cas9 genome editing technology with a single-guide RNA format in any non-cellular or cellular setting, including human and other eukaryotic cells, will be released from the interference absent an appeal, and may ...
- Luxcel, Angiogeneis and BMG Labtech Secure €2.5m from EU (2017-02-15)
Three European technology SME's, together with two internationally recognised research institutions, Oxford University and Imperial College London, have been awarded €2.5m funding from the European commission under the H2020 Fast Track to Innovation (FTI) pilot, to...
- Boehringer & Weill Cornell Medicine: COPD Drug Discovery (2017-02-15)
> Boehringer Ingelheim and Weill Cornell Medicine to identify novel treatment approaches that could halt or even reverse lung tissue damage in COPD > The collaboration is part of the ongoing Boehringer Ingelheim commitment to bring new medicines that address un...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to email@example.com and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]